COVID-19 Research Paper Volume 13, Issue 6 pp 7733—7744
Lymphocyte may be a reference index of the outcome of cancer patients with COVID-19
Figure 2. Circulating immune cell subpopulation on admission of cancer patients with COVID-19. Counts of T lymphocytes, B lymphocytes, Th cells, Ts cells, and NK cells were tested on admission of cancer patients with COVID-19 divided by the outcome (A). Counts of T lymphocytes, B lymphocytes, Th cells, and Ts cells were diminished on admission of cancer patients with COVID-19 (B). Count of B lymphocytes and Th cells were correlated with survival time of cancer patients with COVID-19 (C).